Merck & Co Inc (NYSE: MRK) In 2024: Will It Be A Valuable Investment?

In the last trading session, 5.07 million shares of the Merck & Co Inc (NYSE:MRK) were traded, and its beta was 0.39. Most recently the company’s share price was $130.99, and it changed around -$0.96 or -0.73% from the last close, which brings the market valuation of the company to $331.75B. MRK currently trades at a discount to its 52-week high of $133.10, offering almost -1.61% off that amount. The share price’s 52-week low was $99.14, which indicates that the current value has risen by an impressive 24.31% since then. We note from Merck & Co Inc’s average daily trading volume that its 10-day average is 13.42 million shares, with the 3-month average coming to 8.76 million.

Merck & Co Inc stock received a consensus recommendation rating of Hold, based on a mean score of 1.62. If we narrow it down even further, the data shows that 0 out of 21 analysts rate the stock as a Sell; another 4 rate it as Overweight. Among the rest, 10 recommended MRK as a Hold, whereas 7 deemed it a Buy, and 0 rated it as Underweight. Merck & Co Inc is expected to report earnings per share of $2.05 for the current quarter.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Merck & Co Inc (NYSE:MRK) trade information

Instantly MRK has showed a red trend with a performance of -0.73% at the end of last trading. The performance over the last five days has remained in the green territory. The company’s shares are currently up 20.15% year-to-date, but still up 5.77% over the last five days. On the other hand, Merck & Co Inc (NYSE:MRK) is 3.02% up in the 30-day period. We can see from the shorts that 23.16 million shares have been sold at a short interest cover period of 2.41 day(s).

The consensus price target as assigned by Wall Street analysts is $118.74, which translates to bulls needing to decrease their stock price by -10.32% from its current value. Analyst projections state that MRK is forecast to be at a low of $80 and a high of $294.

Merck & Co Inc (MRK) estimates and forecasts

Merck & Co Inc share prices are performing particularly well compared to other companies within the same industry. As is evident from the statistics, the company’s shares have risen 25.59 percent over the past six months and at a 468.87% annual growth rate that is well above the industry average of 4.20%. Moreover, analysts have decided to roll up on their fiscal year 2024 revenue estimates. The rating firms predict that it will gain 46.40% in revenue this quarter, and will report an increase of 198.10% in the next quarter. The year-over-year growth rate is expected to be 6.20%, up from the previous year.

Consensus estimates provided by 12 financial analysts predict the company will bring in an average of $15.13 billion in revenue for the current quarter. 12 analysts expect Merck & Co Inc to make $15.84 billion in revenue for the quarter ending Jun 2024. The company’s sales for the same quarters a year ago were $13.78 billion and $15.04 billion respectively. Analysts predict that the company’s current quarter sales will jump, forecast at 9.70%. Forecasts for the next quarter put sales growth at 5.40%.

Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -42.70%. Merck & Co Inc earnings are expected to increase by 468.66% in 2024, but the outlook is positive 67.56% per year for the next five years.

MRK Dividends

Merck & Co Inc’s next quarterly earnings report is expected to be released on April 25. The annual dividend yield of the stock is 2.29 percent and its annual dividend per share was 3.00. It is important to note, however, that the 2.29% dividend yield ratio should be regarded as a guide only, as many other factors should be taken into consideration before making any investment decision.

Merck & Co Inc (NYSE:MRK)’s Major holders

Upon looking at major shareholders, it appears that insiders hold 0.07% of Merck & Co Inc shares, and 78.59% of them are in the hands of institutional investors. The stock currently has a share float of 78.65%. Merck & Co Inc stock is held by 4,289 institutions, with Vanguard Group Inc being the largest institutional investor. By Jun 29, 2023, it held 9.60% of the shares, which is about 243.64 million shares worth $28.11 billion.

Blackrock Inc., with 8.10% or 205.65 million shares worth $23.73 billion as of Jun 29, 2023, holds the second largest percentage of outstanding shares.

Vanguard Total Stock Market Index Fund and Vanguard 500 Index Fund were the top two Mutual Funds as of Jun 29, 2023. The former held 79.16 million shares worth $9.13 billion, making up 3.12% of all outstanding shares. On the other hand, Vanguard 500 Index Fund held roughly 60.41 million shares worth around $6.97 billion, which represents about 2.38% of the total shares outstanding.